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Phosphorylation regulating the  
ratio of intracellular crY1 Protein 
Determines the circadian Period
Na Liu1,2 and Eric Erquan Zhang2*
1 College of Life Sciences, Beijing Normal University, Beijing, China, 2 National Institute of Biological Sciences, Beijing, China
The core circadian oscillator in mammals is composed of transcription/translation feed-
back loop, in which cryptochrome (CRY) proteins play critical roles as repressors of their 
own gene expression. Although post-translational modifications, such as phosphoryla-
tion of CRY1, are crucial for circadian rhythm, little is known about how phosphorylated 
CRY1 contributes to the molecular clockwork. To address this, we created a series of 
CRY1 mutants with single amino acid substitutions at potential phosphorylation sites 
and performed a cell-based, phenotype-rescuing screen to identify mutants with aber-
rant rhythmicity in CRY-deficient cells. We report 10 mutants with an abnormal circadian 
period length, including long period (S280D and S588D), short period (S158D, S247D, 
T249D, Y266D, Y273D, and Y432D), and arrhythmicity (S71D and S404D). When 
expressing mutated CRY1 in HEK293 cells, we show that most of the mutants (S71D, 
S247D, T249D, Y266D, Y273D, and Y432D) exhibited reduction in repression activity 
compared with wild-type (WT) CRY1, whereas other mutants had no obvious change. 
Correspondingly, these mutants also showed differences in protein stability and cellular 
localization. We show that most of mutants are more stable than WT, except S158D, 
T249D, and S280D. Although the characteristics of the 10 mutants are various, they 
all impair the ratio balance of intracellular CRY1 protein. Thus, we conclude that the 
mutations caused distinct phenotypes most likely through the ratio of functional CRY1 
protein in cells.
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inTrODUcTiOn
To adapt to dramatic changes in environmental conditions, living organisms from fungi to humans 
have evolved an internal biological clock (1). In mammals, the circadian clock is an endogenously 
driven 24-h cycle affecting behavior, physiology, and metabolism (2). The core circadian oscillator is 
a transcription/translation feedback loop (TTFL) in which CLOCK and BMAL1 are activators that 
dimerize and promote the expression of cryptochrome (CRY) and period (PER) genes. After transla-
tion, CRY and PER form heterodimers and translocate to the nucleus where they act as repressors 
and inhibit their own expression. When nuclear localized CRY and PER proteins are degraded, the 
inhibition is relieved; the next circadian cycle is subsequently initiated (3).
Although the mechanism by which CRY and PER repress the transcriptional activation of 
CLOCK:BMAL1 is not well understood, post-translational modifications, such as the phospho-
rylation of CRY and PER proteins, are closely linked to the inhibition of transcription (4). The 
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phosphorylation of PER proteins regulates their stability and 
their subcellular localization. In addition, different phosphoryla-
tion events can lead to phenotypes of opposite periodicity, such 
as the mutation in patients suffering from familial advanced 
sleep phase syndrome (FASPS) (5). In mammals, the CRY 
proteins, CRY1 and CRY2, are essential for the maintenance of 
circadian rhythms, and their absence results in arrhythmicity in 
constant darkness. In addition, CRY1 and CRY2 play different 
roles in regulating the circadian clock because mice lacking 
CRY1 or CRY2 exhibit short or long periods, respectively (6, 
7). CRY1 and CRY2 are highly conserved proteins consisting 
of an N-terminal photolyase homology (PHR) domain, which 
binds to the flavin adenine dinucleotide (FAD) cofactor and 
divergent C-terminal tails (8). In CRY2, the phosphorylation 
of ser265 and ser553/ser557 may affect FAD positioning and 
electron transport, and proteasome degradation resulting in a 
shortened circadian period (9, 10). CRY1 phosphorylation in the 
PHR domain and C-terminal tail indicates that protein stability 
is linked to abnormal circadian rhythms (11, 12). Recent studies 
have shown that the stability of CRY proteins is regulated by 
two competing SCF E3 ligase complexes. The FBXL3 complex 
mediates degradation of CRY protein in the nucleus, while the 
FBXL21 complex protects CRY from FBXL3 degradation in 
the nucleus and promotes CRY degradation in the cytoplasm 
(13, 14). Although post-translational modifications of CRY1 
are crucial for circadian rhythms, little is known about which 
CRY1 phosphorylation sites have the most impact. Therefore, 
we conducted a cell-based screen to identify phosphorylation 
residues in mCRY1 that rescue rhythmicity in CRY1/CRY2 
double-deficient cells (DKO cells) to better understand the 
role of phosphorylated CRY1 in clock function. We identified 
phosphorylation sites that cause long periods, short periods, or 
even arrhythmicity.
MaTerials anD MeThODs
Dna Plasmids and cells
P(Cry1)-CRY1 was constructed by replacing the P(CMV) pro-
moter of pcDNA3.1-Cry1-Flag with the mCRY1 native promoter 
(1.5  kb) and the first intron (15). All of the mutations were 
generated using the KOD-plus-mutagenesis kit and confirmed 
by sequencing. HEK293 cells were purchased from the American 
Type Culture Collection (ATCC).
Kinetic Bioluminescence recording
Real-time circadian reporter assays were performed as 
 previously described (16, 17). One the day prior transfection, 
approximately 3–5 ×  104 DKO cells were plated onto 35-mm 
culture dishes. Cells were cotransfected using the X-treme 
GENE HP DNA transfection reagent (Roche) with 1  μg of 
pGL3-P(Per2)-dLuc reporter plasmid and 50  ng of a CRY 
expression plasmid. Three days after transfection, the cells were 
treated with 0.1-mM dexamethasone (Sigma) for 2 h and then 
placed in XM medium as previously described (18). The kinetic 
bioluminescence was recorded using a Lumicycle luminometer 
(Actimetrics, Inc.) at 36°C.
luciferase repression assay
HEK293 cells were grown and transfected in 96-well plates. For 
transfection, 10 ng of the reporter plasmid pGL3-P(Per2)-dLuc was 
combined with 5 ng of a CRY expression plasmid, 10 ng of BMAL1, 
and 15 ng of the CLOCK plasmid. Empty vector pcDNA3.1 was 
added as necessary to obtain total DNA concentration of 200 ng 
per well. Twenty-four hours after transfection, cells were prepared 
for the Dual-Luciferase Reporter Assay System (Promega).
luciferase complementation assay
Luciferase complementation assay is used to determine the inter-
action of proteins (19). The N-terminal luciferase fragment was 
fused to the N-terminus of mCRY1 [wild type (WT) or mutant] 
and the C-terminal luciferase fragment to the C-terminus of 
mFBXL3 (or mPER2). mCRY1 (WT or mutant) and mFBXL3 
(or mPER2) were co-expressed as fusion proteins with luciferase 
fragments in HEK293 cells. Twenty-four hours after transfec-
tion, cells were prepared for the Dual-Luciferase Reporter Assay 
System (Promega).
global Protein stability assay
Assays using the global protein stability (GPS) system were per-
formed as described, with minor modifications (20). The GPS sys-
tem was used to detect the stabilization of WT CRY1 and mutants. 
The lentiviral reporter construct contains a single promoter and 
an internal ribosome entry site (IRES) that permits the translation 
of two fluorescent proteins (DsRed and EGFP) from one mRNA 
transcript. DsRed served as an internal control, whereas EGFP was 
expressed as a fusion with our protein of interest. When integrated 
into the genome, the ratio of EGFP/DsRed can be quantified by 
fluorescence-activated cell sorting (FACS), producing a ratio 
that represents the stability of target proteins. The d1EGFP and 
d4EGFP represent half-life at 1 and 4 h, respectively.
subcellular localization assay
HEK293 cells were transfected with a plasmid encoding GFP-
mCRY1 (WT or mutant). Twenty-four hours after transfection, 
the cells were stained with Hoechst 33258 (Sigma) and fixed with 
4% paraformaldehyde in PBS. Samples were observed using Zeiss 
confocal LSM800 with a 63× water-immersion objective, and the 
data were analyzed using Image J software.
statistical analysis
In all experiments, unless noted, error bars represent SEM (n ≥ 3 
for each experiment). Statistical significance was determined 
using one-way ANOVA with Dunnett’s multiple comparisons 
test when comparing each mean to a control mean. All statistical 
analyses were performed using GraphPad Prism 6 (GraphPad 
Software, Inc., La Jolla, USA). *p < 0.05, **p < 0.01, ***p < 0.001, 
and ****p < 0.0001.
resUlTs
The Phosphorylation of crY1 regulates 
circadian rhythms
The importance of core clock protein phosphorylation in the 
mammalian circadian system is widely accepted (4). However, 
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little is known about the amount or location of  phosphorylated 
CRY1 protein residues or how phosphorylation affects the 
molecular clockwork. In this study, we performed a cell-based 
screen to identify the phosphorylated residues in mCRY1 critical 
for rescuing rhythmicity in DKO cells. CRY1-mediated rescue of 
clock oscillation in DKO cells has been observed after transfec-
tion with CRY1 DNA concentrations ranging from 3 to 800 ng 
(Figure 1A). Our data show that 3 ng of CRY1 DNA was insuffi-
cient to rescue circadian rhythmicity, while 800 ng of CRY1 DNA 
restored circadian rhythms with low amplitude that were quickly 
dampened. Using 50 ng of CRY1 DNA, we rescued a circadian 
rhythmicity of approximately 24.6 h (Figure 1G).
In our screen, phosphomimetics were created to identify 
potential phosphorylation sites in human, mouse, and rat 
(Table  1). We found 10 mutants with abnormal periodical 
phenotypes (Figures  1B–F). Our data demonstrate the follow-
ing: (1) substitution of serine (S) 71 and 404 with aspartic (D) 
prevented the rescue of circadian rhythmicity (Figure  1B); (2) 
the phosphomimetic mutants for S158D, S247D, and T249D 
restored circadian rhythms with short periods (S158D, −1.3 h; 
S247D, −3.5 h; S249D, −3.3 h) (Figure 1G); (3) the mutants with 
Y266D, Y273D, and Y432D rescued circadian rhythms with short 
periods (Y266D, −1.9  h; Y273D, −2.7  h; Y432D, −1.8  h), low 
amplitudes, and quick damping (Figure 1G); (4) the S280D and 
S588D mutants restored circadian rhythms with long periods, 
especially S588D (S588D, +3.2 h; S280D, +1.6 h) (Figure 1G), 
which is consistent with previous reports (12); and (5) the phos-
phorylation of serines 281, 575, 595, and 604 had no obvious 
effect on circadian rhythms (Figure  1G). Thus, we established 
that most of the phosphorylation sites on CRY1 play distinct roles 
in the mechanism of the molecular clockwork.
To determine whether non-phosphorylation of the phospho-
rylated sites alters CRY1’s function, we generated non-phosphom-
imetic mutants of CRY1 with Ser/Thr/Tyr changed to Ala or Phe. 
Our results showed that all of the non-phosphomimetic mutants 
(S71A, S247A, T249A, S280A, Y266F, Y273F, Y432F, S404A, and 
S588A) exhibited lack of effect on the circadian period (Figure 1).
effects of Mutant mcrY1 on BMal1: 
clOcK-induced Transcriptional activation
To determine how CRY1 phosphorylation affects the molecular 
clockwork, we used a transcriptional assay to analyze the functional 
significance of the phosphomimetic mutants. Co-expression of 
CLOCK and BMAL1 stimulated E-box element-dependent tran-
scription of a luciferase reporter gene in HEK293T cells, which 
was markedly suppressed by the expression of WT mCRY1 under 
the control of cytomegalovirus (CMV) promoter [P(CMV)] or 
the native mCRY1 promoter [P(Cry1)] (Figures 2A,B). We then 
constructed mutants by replacing phospho-acceptor Ser/Tyr/Trp 
residues with Asp, which mimics phosphorylation. The phos-
phomimetic mCRY1 mutants were used to determine the role 
of each residue in inhibiting transcription. Compared with WT 
mCRY1, the mCRY1 mutants fell into two phenotypic groups: 
strong repression (>60% of WT repression activity) that had 
similar repression activity to WT and weak repression (<20% of 
WT repression activity) with a significant reduction in repression 
activity (Figures  2A,B). The results showed that WT mCRY1 
had strong repression activity that repressed the transcriptional 
activation to 3% driven by CMV promoter and to 20% driven by 
mCRY1 promoter. In addition, six Asp mutants (S71D, S247D, 
T249D, Y266D, Y273D, and Y432D) repressed the transcrip-
tional activation to 16–50% and to 53–85%, respectively, under 
the control of CMV and mCRY1 promoter, exhibiting significant 
reductions in repression activity (p < 0.01, ANOVA). However, 
the other four Asp mutants (S158D, S280D, S404D, and S588D) 
exhibited no obvious change in repression activity (p >  0.05, 
ANOVA), although the repression activity of S404D was slightly 
stronger than WT (Figures 2A,B).
effects of Phosphomimetic Mutation on 
mcrY1 Protein stability and interactions 
with FBXl3 and Per2
Previous reports have shown that phosphorylation of mCRY1 at 
S247 does not affect protein stability (9). Therefore, we investi-
gated whether phosphorylation of other residues that regulate 
mCRY1’s function (Figures  2A,B) alters protein stability. The 
GPS system utilizes an internally normalized fluorescent-based 
reporter system combined with FACS to detect real-time protein 
stability at the level of individual living cells (20, 22). GPS vectors 
expressed a single transcript encoding DsRed and EGFP target 
separated by an IRES (Figure  3A). The coding sequence for 
DsRed–IRES–EGFP–mCRY1 (WT or mutant) was cloned into 
a lentiviral vector. After infection by the lentivirus, HEK293 cells 
stably expressing DsRed and EGFP–mCRY1 (WT or mutant) 
were analyzed by flow cytometry. The EGFP/DsRed ratio acts as a 
reporter for stability of the expressed WT or mutant mCRY1. The 
d1EGFP (t1/2 = 1 h) and d4EGFP (t1/2 = 4 h) represent the half-
life markers. Our results show that the half-life of WT mCRY1 is 
similar to that of d1EGFP (Figure 3B, top). The S158D, T249D, 
and S280D mutations exhibited no obvious change compared to 
WT mCRY1 (Figure 3B, middle). Surprisingly, the S71D, S404D, 
Y266D, Y273D, Y432D, and S588D mutations displayed half-
lives longer than that of WT mCRY1 (Figure 3B, bottom), despite 
variations in the rescued period length (Figure 1G).
The crystal structure of mCRY1 reveals that binding sites 
for mPER2 and FBXL3, which partially overlap, are involved in 
transcriptional repression and protein stability (19, 23). To deter-
mine whether mCRY1 phosphorylation affects interactions with 
mFBXL3 and PER2, we used a luciferase complementation assay 
to determine how mFBXL3 or PER2 interact with phosphomi-
metic mCRY1 mutants (Figure 3C). WT or mCRY1 mutants and 
mFBXL3 (or PER2) were co-expressed as fusion proteins with 
N- and C-terminal luciferase fragments in HEK293 cells (19). 
Formation of mCRY1-FBXL3 (or PER2) complexes produces 
functional luciferase and that can be recorded in luciferin-
containing medium. Data showed that, to varying degrees, all 
of the mutations reduced mFBXL3 binding. In particular, the 
S71D, Y266D, Y273D, S404D, and Y432D mutations drastically 
reduced mFBXL3 binding to 4, 11, 23, 32, and 11%, respectively 
(Figure 3C, top). By contrast, mPER2 binding was unaffected by 
the S158D, T249D, S280D, S404D, and S588D mutations, while 
the S71D, Y266D, Y273D, and Y432D mutations weakened the 
FigUre 1 | a cell-based screen to identify critical phosphorylation residues on mcrY1 through rescuing rhythmicity in Cry1−/−:Cry2−/− fibroblasts 
(DKO cells). (a) Dosage-dependent rescue of circadian rhythms in DKO cells by mCRY1. The mCRY1 expression vector was cotransfected into cells with the 
P(Per2)-dLuc reporter vector. Three days after transfection, the cells were synchronized by dexamethasone treatment and then moved to luciferin-containing 
medium for 5–6 days of bioluminescence recording. (B–F) The P(Per2)-dLuc reporter rhythms (baseline subtracted) from DKO cells transfected with WT or mutant 
mCRY1, as noted in the legend. Experiments were performed as in (a). (g) Quantitation of the period length from WT and mutant mCRY1 transfected cells that 
showed a distinct period phenotype as noted in the legend. Error bars represent SEM (n ≥ 5, **p < 0.01; ***p < 0.001; ****p < 0.0001, ANOVA).
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FigUre 2 | effects of mutant mcrY1 on BMal1: clOcK-induced transcriptional activation. (a) HEK293 cells were cotransfected with BMAL1  
(10 ng plasmid), CLOCK (15 ng) expression plasmid, and Per2-dluc (10 ng) reporter with WT or mutant mCRY1 (5 ng) as noted. Twenty-four hours after transfection, 
the cells were changed to luciferin-containing medium for end-point bioluminescence recording. The raw data were normalized such that the reporter control without 
mCRY1 (WT or mutant) transfection was equal to 100%. Compared with WT mCRY1, the mutants exhibited two profiles: strong repression with similar repression 
activity to WT and weak repression with a significant reduction in repression activity. Mean and error bars (SEM) of three independent transfections are shown 
(****p < 0.0001, ANOVA). Two additional experiments gave similar results. (B) DKO cells were cotransfected with Per2-dluc (10 ng) reporter and WT or mutant 
mCRY1 (50 ng) as noted. Experiments and data analysis were done as in (a). Compared with WT, the mutants exhibited two profiles: strong repression with similar 
repression activity as WT and weak repression with a significant difference. Mean and error bars (SEM) of three independent transfections are shown  
(**p < 0.01, ***p < 0.001, ****p < 0.0001, ANOVA). Two additional experiments gave similar results.
TaBle 1 | Phosphorylated residues of crY1 (mouse, human, and rat) are written in red.
Mouse human rat
S71-p ANLRKLNsRLFVIRG S71 ANLRKLNSRLFVIRG S71 ANLRKLNSRLFVIRG
S158-p KRFQTLVsKMEPLEM S158 KRFQTLISKMEPLEI S158 KRFQTLVSKMEPLEM
S247-p NANSLLAsPtGLSPY S247 NANSLLASPTGLSPY S247 NANSLLASPTGLSPY
T249-p NSLLAsPtGLSPYLR T249 NSLLASPTGLSPYLR T249 NSLLASPTGLSPYLR
Y266 CLSCRLFYFKLTDLY Y266 CLSCRLFYFKLTDLY Y266-p CLSCRLFyFKLTDLy
Y273 YFKLTDLYKKVKKNs Y273 YFKLTDLYKKVKKNS Y273-p yFKLTDLyKKVKKNS
S280-p YKKVKKNssPPLSLY S280 YKKVKKNSSPPLsLY S280 yKKVKKNSSPPLSLY
S281-p KKVKKNssPPLSLYG S281 KKVKKNSSPPLsLYG S281 KKVKKNSSPPLSLYG
S285 KNssPPLSLYGQLLW S285-p KNSSPPLsLYGQLLW S285 KNSSPPLSLYGQLLW
Y432 NGDYIRRYLPVLRGF Y432-p NGDYIRRyLPVLRGF Y432 NGDYIRRYLPVLRGF
S575-p HSLKQGRsSAGTGLS S555 HLLKQGRSSMGTGLS S557 NPLKQGRSSMGTGLS
S588-p LSSGKRPsQEEDAQs S568-p LSGGKRPsQEEDTQS S570 LSSGKRPSQEEDAQS
S595-p sQEEDAQsVGPKVQR S575 sQEEDTQSIGPKVQR S577 SQEEDAQSVGPKVQR
S604-p GPKVQRQsSN_____ S584 GPKVQRQSTN_____ S586 GPKVQRQSSN_____
The resource is from PhosphoSitePlus database (21).
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interactions with mPER2 to 4, 10, 43, and 18%, respectively 
(Figure 3C, bottom). We conclude that phosphomimetic muta-
tions affect the stability and transcriptional repression activity of 
mCRY1 by antagonizing with mFBXL3 and PER2.
effects of Phosphomimetic Mutation on 
mcrY1 Protein subcellular localization
The stability of CRY1 protein is regulated by two competing 
SCF E3 ligase complexes: FBXL3 mediates degradation in the 
nucleus, while FBXL21 protects CRY1 in the nucleus and facili-
tates degradation in the cytoplasm (13, 14). Therefore, we sought 
to determine whether phosphomimetic mutations alter the 
subcellular localization of mCRY1. To determine the subcellular 
distribution pattern of the mutants, we generated a GFP-tagged 
mCRY1 (WT or mutant) expression construct. Representative 
images of GFP-mCRY1 (WT or mutant), as detected by GFP 
fluorescence, are shown in Figure  4A. The ratio of cells with 
subcellular distribution and the colocalization of GFP-mCRY1 
(WT or mutant) proteins with nuclei are shown in Figures 4B,C. 
In transient transfection assays using HEK293 cells, the mutants 
were predominantly localized in the nucleus and cytoplasm. 
However, 5–65% of S158D, S249D, S280D, or S404D-GFP were 
localized exclusively in the nucleus, similarly to WT, with a 
colocalization efficiency of more than 75%. In contrast, 6–42% of 
S71D, Y266D, Y273D, Y432D, or S588D-GFP were only observed 
in the cytoplasm, with a nuclear colocalization efficiency of less 
than 63%, especially S71D (~29%) (Figures 4B,C). Based on these 
data, we conclude that the phosphorylation of mCRY1 at amino 
acid sites S71, Y266, Y273, Y432, and S588 alter the subcellular 
localization that is critical for the rhythmicity of circadian clock.
Although the mutants S158D, S247D, and T249D showed 
similar periodical phenotypes with Y266D, Y273D, and Y432D, 
FigUre 3 | effects of phosphomimetic mutation on mcrY1 protein stability and interactions with FBXl3 and Per2. (a) Global protein stability (GPS) 
reporter system. The DsRed–IRES–EGFP target element was cloned into a lentiviral vector, and the fluorescent reporter proteins were co-expressed from a single mRNA 
via an internal ribosomal entry site (IRES). (B) HEK293 cells were infected with lentivirus of pLv–DsRed–IRES–EGFP–mCRY1 (WT or mutant) for 24 h, and then the 
fluorescent protein signals were analyzed by flow cytometry. The EGFP/DsRed ratio acts as a reporter for stability of the expressed WT or mutant mCRY1. The d1EGFP 
and d4EGFP are markers for 1- and 4-h half-lives, respectively. (c) Luciferase complementation assay. mCRY1 (WT or mutant) and FBXL3 (or PER2) were co-expressed 
as fusion proteins with luciferase fragments in HEK293 cells. Experiments were done as in Figure 2a and the data presented relative to mCRY1 (WT)-mFBXL3 (or 
mPER2). Mean and error bars (SEM) of three independent transfections are shown (****p < 0.0001, ANOVA). Two additional experiments gave similar results.
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the subcellular location of the proteins had no obvious change, 
suggesting that the mechanisms were different. Indeed, the iden-
tified phosphorylated sites were located in different functional 
regions of mCRY1 (Figure 4D), supporting our conclusion that 
the phosphorylation of these sites with different repression activ-
ity, protein stability, and subcellular location results in various 
periodical phenotypes by distinct mechanisms.
DiscUssiOn
In the basic TTFL model, both positive and negative regula-
tory elements are important for generating the autoregulatory 
feedback loop. Post-translational regulation of the activity, 
degradation, and localization of these regulators, most notably 
phosphorylation influences the circadian rhythms (4, 25). 
Although many CRY1phosphorylation sites have been identified, 
their contribution to clock function was unclear. We conducted 
a cell-based screen in CRY-deficient (DKO) cells and identified 
10 phosphomimetic mutants of mCRY1 that induce abnormal 
circadian periods, including long period (S280D and S588D), 
short period (S158D, S247D, T249D, Y266D, Y273D, and 
Y432D), and even arrhythmicity (S71D and S404D). The period 
length of the circadian clock in cells is complicated because many 
genes participate in regulating the circadian period (11, 26–28). 
FigUre 4 | effects of phosphomimetic mutation on subcellular localization of mcrY1 protein. GFP-tagged mCRY1 (WT or mutant) proteins were 
transiently overexpressed in HEK293 cells, and the subcellular distribution pattern of mCRY1 protein was analyzed. (a) Representative images of GFP-mCRY1 (WT 
or mutant) were detected by GFP fluorescence (green), and the nuclei were stained with Hoechst (blue). (B) Percentage of cells showing nuclear (N), nuclear–
cytoplasmic (N + C), and cytoplasmic (C) staining as indicated in the plots. The ratio of cells with subcellular localization to the total transfected cells was analyzed 
by counting 100 cells three times in each experiment. (c) Percentage of colocalization of GFP-mCRY1 (WT or mutant) with nuclei. The 50 GFP-mCRY1 (WT or 
mutant)-expressing cells were analyzed by Image J software (Version 1.37c, NIH, USA). Mean and error bars (SEM) are shown (n = 3 for each experiment). Two 
additional experiments gave similar results (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, ANOVA). (D) Location of the important phosphorylated sites on the 
liner protein functional regions of mCRY1. The FAD binding domain, which contains phosphate binding loop, protrusion loop, C-terminal lid (Lid), and nuclear 
localization signal (NLS), has been indicated in this schematic diagram. The diagram was constructed using Illustrator for Biological Sequences (IBS) software (24).
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TaBle 2 | Phosphorylation regulating the ratio of intracellular mcrY1 determines the circadian period length by different mechanisms.
Phosphomimetic 
mutants
Period 
phenotype
repression 
activity
Protein 
stability
nuclear  
colocalization
Potential mechanism
S71D
AR
↓ ↑ ↓ The mutant cannot enter the nucleus, as the binding to PER2 is too weak
S404D ↑ ↑ N The degradation is weak, as the binding to FBXL3 is weak
S158D  
 
 
 
S
N N N Introduction of negative charge to the surface region alters the interaction with 
other proteins
S247D ↓ — — The mutants enforce the phosphate-binding conformation to tune FAD, ultimately 
leading to change in mCRY1 protein functionT249D ↓ N N
Y266D ↓ ↑ ↓ Lower nuclear localization efficiency may be due to weak interaction with FBXL3 
and PER2
Y273D ↓ ↑ ↓
Y432D ↓ ↑ ↓
S280D
L
N N N The binding to FBXL3 is weak, as S280 is located in protrusion loop, which 
interacts with FBXL3 and constricts access to FAD
S588D N ↑ ↓ The ratio of nuclear protein is decreased. This may be due to S588 nearing the 
NLS sequence
AR, arrhythmicity; S, short period; L, long period; ↑, increase; ↓, decrease; N, no obvious change; —, no result.
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In this study, we identified mutations that alter repression activity, 
protein stability, and cellular localization, suggesting that distinct 
mechanisms regulate each phenotype.
Previously, we have demonstrated that the proper ratio of 
intercellular CRY proteins determines the normal clock period 
length (17). In this study, we further determined that the ratio 
of functional CRY1 protein is regulated by phosphorylation in 
cells and the ratio imbalance disrupts circadian rhythmicity, 
although the mechanisms are different (Table  2). The S280D 
mutation displayed a long period, similar to that of S588D [pre-
viously reported in Ref. (12)]. We found that phosphorylation 
at S588 decreased nuclear protein localization and weakened 
interactions with FBXL3, increasing the protein stability. This 
may be due to the position of the S588 residue, which is near 
the NLS sequence of the C-terminal tail of mCRY1. The crystal 
structure of mCRY1 (19) shows that FBXL3, but not PER2, 
binds across the protrusion loop (S280) and the phosphate-
binding loop (S247 and T249) (Figure 4D). Consistently, the 
S280D and T249D mutations reduced FBXL3 binding but 
did not affect PER2 binding (Figure  3C). In addition, the 
phosphate-binding and protrusion loops, with conformational 
flexibility, constrict the approach to FAD, which is critical to 
CRY1’s functions. Phospho-Ser-mimicking mutations at this 
region may enforce the phosphate-binding conformation to 
tune FAD, ultimately leading to a change in mCRY1 protein 
function (8). Introduction of negative charge (Asp) to site S158, 
located in the surface region (19), may restructure and/or disor-
der the structural conformation between the phosphorylation 
site and nearby amino acid residues, affecting mCRY1’s clock 
function. The Y266D, Y273D, and Y432D mutations displayed 
similar phenotype (short period, Figure 1D), weaker interac-
tions with FBXL3 and PER2, and lower nuclear colocalization 
efficiency compared with WT-mCRY1. Interestingly, although 
the S71D mutant and S404D mutant are arrhythmic, their 
molecular character is very different. The S71D mutant dis-
played almost no interactions with FBXL3 and PER2 and high 
colocalization efficiency with the cytoplasm. Regardless of a 
subtle difference with previous reports (11), in which the S71D 
mutation increased interaction with FBXL3, phosphorylation 
at S71 is crucial for regulating circadian period. In addition, 
phosphorylation at these sites weakens the binding with PER2, 
slowing the rate of nuclear translocation and decreasing the 
concentration of functional protein (3, 29). Nuclear transport 
of the PER/CRY complex is reported to be one of the most 
important mechanisms for period regulation, as shown in the 
recent report on nuclear importin KPNB1 (30). In contrast, the 
phosphomimetic mutation of S404, located in the C-terminal 
lid, did not rescue DKO cells with hyper-repression activity 
(Figures 2A,B) and hypo-interactions with FBXL3 increasing 
protein stability. Neither did it affect binding to PER2 nor 
nuclear colocalization. We hypothesized that the S404D mutant 
binding to FBXL3 was very weak, thus slowing degradation, 
prolonging interactions with the BMAL1/CLOCK complex, 
and ultimately preventing the relief of inhibition and initiation 
of the next circadian cycle (31).
In summary, we identified critical CRY1 sites where mutations 
disrupted circadian rhythmicity. Although some enzymes corre-
spond to specific modifications in mCRY1, such as MAPK at S247 
and AMPK at S71 and S280 (9, 11), the enzymes that modify the 
other sites are unknown. In addition, the effect of modifiers on 
rhythmicity varies after blocking (28), but how the enzymes work 
on the circadian clock components remains unclear. Our data 
indicate that key modifiers of CRY1 directly regulate the ratio of 
functional CRY1 protein by distinct mechanisms that determine 
the circadian rhythmicity, providing new insights on regulation 
of the circadian period.
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